"New England Eye Center – Boston is the main office for the large ophthalmology practice which serves the region with seven additional community locations throughout Eastern Massachusetts. The Boston office offers a full range of comprehensive specialty services for adults and children. Our patients are referred from all over New England, and sometimes across the globe, to see some of our specialists who have international reputations for their expertise."

During the past decade, New England Eye Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "New England Eye Center" #1 sponsor was "Eyetech Pharmaceuticals" with 2 trials, followed by "Lux Biosciences, Inc." with 2 trials sponsored, "Genentech, Inc." with 1 trials sponsored, "Merck Sharp & Dohme LLC" with 1 trials sponsored and "Otsuka Pharmaceutical Development & Commercialization, Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "New England Eye Center" #1 collaborator was "Pfizer" with 2 trials as a collaborator and "Novartis" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "New England Eye Center" are "Macular Degeneration" (2 trials), "Cornea Transplant" (1 trials), "Corneal Diseases" (1 trials), "Corneal Graft Rejection" (1 trials) and "Corneal Transplantation" (1 trials). Many other conditions were trialed in "New England Eye Center" in a lesser frequency.

Most popular intervention types in "New England Eye Center" are "Drug" (7 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "LX201" (2 trials), "Placebo" (2 trials), "pegaptanib sodium" (2 trials), "Rebamipide" (1 trials) and "denufosol tetrasodium (INS37217) Intravitreal Injection" (1 trials). Other intervention names were less common.

The vast majority of trials in "New England Eye Center" are 7 trials for "All" genders.

Currently, there are NaN active trials in "New England Eye Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in New England Eye Center, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in New England Eye Center, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".